Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.
Arvinas
6 followers
Sumitoma Pharma US
3 followers
DNAnexus
9 followers
Thermo Fisher Scientific
286 followers
Gilead Sciences
215 followers
Regeneron
184 followers
Biogen
167 followers
Illumina
93 followers
Neuralink
91 followers
BioMarin Pharmaceutical
60 followers
Alexion Pharmaceuticals
56 followers
Cytokinetics
21 followers